Heinzerling, Keith

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 545

Treatment for amphetamine withdrawal

Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009) · Cochrane Database of Systematic Reviews

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 120

Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

Ray, L. A., Bujarski, S., Shoptaw, S., Roche, D. J., Heinzerling, K., & Miotto, K. (2017) · Neuropsychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 118

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence

Heinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 105

Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use

Heinzerling, K. G., Swanson, A., Hall, T. M., Yi, Y., Wu, Y., & Shoptaw, S. J. (2014) · Addiction

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 64

Bupropion Hydrochloride versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence

Shoptaw, S., Heinzerling, K. G., Rotheram-Fuller, E., Kao, U. H., Wang, P.-C., Bholat, M. A., & Ling, W. (2008) · Journal of Addictive Diseases

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 54

Feasibility of a social media/online community support group intervention among chronic pain patients on opioid therapy

Young, S. D., Koussa, M., Lee, S.-J., Perez, H., Gill, N., Gelberg, L., & Heinzerling, K. (2018) · Journal of Addictive Diseases

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 45

Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder

Heinzerling, K. G., Briones, M., Thames, A. D., Hinkin, C. H., Zhu, T., Wu, Y. N., & Shoptaw, S. J. (2020) · Journal of Neuroimmune Pharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 30

Social media as an emerging tool for reducing prescription opioid misuse risk factors

Young, S. D., Lee, S.-J., Perez, H., Gill, N., Gelberg, L., & Heinzerling, K. (2020) · Heliyon

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 27

Ibudilast may improve attention during early abstinence from methamphetamine

Birath, J. B., Briones, M., Amaya, S., Shoptaw, S., Swanson, A.-N., Tsuang, J., Furst, B., Heinzerling, K., Obermeit, L., Maes, L., et al. (2017) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesAttention Deficit Hyperactivity Disorder

Cited by 19